nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer
|
Maroun, J.A. |
|
2006 |
42 |
2 |
p. 193-199 7 p. |
artikel |
2 |
A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: A study by the Scottish Gynaecological Cancer Trials Group (SGCTG)
|
Reed, N.S. |
|
2006 |
42 |
2 |
p. 179-185 7 p. |
artikel |
3 |
A study from the EORTC new drug development group: Open label phase II study of sabarubicin (MEN-10755) in patients with progressive hormone refractory prostate cancer
|
Fiedler, W. |
|
2006 |
42 |
2 |
p. 200-204 5 p. |
artikel |
4 |
Borderline tumours of the ovary and fertility
|
Morice, P. |
|
2006 |
42 |
2 |
p. 149-158 10 p. |
artikel |
5 |
Calendar
|
|
|
2006 |
42 |
2 |
p. I-II nvt p. |
artikel |
6 |
Cancer and pregnancy: Poena magna, not anymore
|
Pentheroudakis, George |
|
2006 |
42 |
2 |
p. 126-140 15 p. |
artikel |
7 |
Cancer survival in the elderly: Effects of socio-economic factors and health care system features (ELDCARE project)
|
Vercelli, Marina |
|
2006 |
42 |
2 |
p. 234-242 9 p. |
artikel |
8 |
Editorial board
|
|
|
2006 |
42 |
2 |
p. ii- 1 p. |
artikel |
9 |
Ejc news copy vol. 42 issue 2 (february 2006)
|
|
|
2006 |
42 |
2 |
p. 119-123 5 p. |
artikel |
10 |
Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: Hypermethylation-independent mechanisms of inactivation
|
Wethkamp, Nils |
|
2006 |
42 |
2 |
p. 264-274 11 p. |
artikel |
11 |
Forthcoming papers
|
|
|
2006 |
42 |
2 |
p. xii- 1 p. |
artikel |
12 |
Genotyping and phenotyping cytochrome P450: Perspectives for cancer treatment
|
Mathijssen, Ron H.J. |
|
2006 |
42 |
2 |
p. 141-148 8 p. |
artikel |
13 |
Identification of HNP3 as a tumour marker in CD4+ and CD4− lymphocytes of patients with cutaneous T-cell lymphoma
|
Escher, Niko |
|
2006 |
42 |
2 |
p. 249-255 7 p. |
artikel |
14 |
Inherent pacemaker function of duodenal GIST
|
Furuzono, Shinji |
|
2006 |
42 |
2 |
p. 243-248 6 p. |
artikel |
15 |
In this issue
|
|
|
2006 |
42 |
2 |
p. xi- 1 p. |
artikel |
16 |
In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection
|
Rutkowski, P. |
|
2006 |
42 |
2 |
p. 159-164 6 p. |
artikel |
17 |
Management and prognosis of esophageal cancers: Has progress been made?
|
Bouvier, A.M. |
|
2006 |
42 |
2 |
p. 228-233 6 p. |
artikel |
18 |
Parenteral nutrition is not superior to replacement fluid therapy for the supportive treatment of chemotherapy induced oral mucositis in children
|
Schmid, Irene |
|
2006 |
42 |
2 |
p. 205-211 7 p. |
artikel |
19 |
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing
|
Sessa, Cristiana |
|
2006 |
42 |
2 |
p. 171-178 8 p. |
artikel |
20 |
Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer
|
Ohno, Tetsuro |
|
2006 |
42 |
2 |
p. 256-263 8 p. |
artikel |
21 |
Prostate cancer diagnosis: The impact on patients’ mental health
|
Korfage, Ida J. |
|
2006 |
42 |
2 |
p. 165-170 6 p. |
artikel |
22 |
Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysis
|
Butterworth, Adam S. |
|
2006 |
42 |
2 |
p. 216-227 12 p. |
artikel |
23 |
Serum EGFR levels and efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
|
Hudelist, Gernot |
|
2006 |
42 |
2 |
p. 186-192 7 p. |
artikel |
24 |
Targeted kinase inhibitors in lung cancer: From EGFR to patients
|
Apolone, Giovanni |
|
2006 |
42 |
2 |
p. 124-125 2 p. |
artikel |
25 |
Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma
|
Pedeux, Rémy |
|
2006 |
42 |
2 |
p. 212-215 4 p. |
artikel |